Lemaitre Vascular (LMAT) Tops Q4 EPS by 4c

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.13, $0.04 better than the analyst estimate of $0.09. Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.1 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• XP Inc. (XP) Tops Q2 EPS by 8c